Literature DB >> 3938813

Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

Y Sawada, M Hanano, Y Sugiyama, T Iga.   

Abstract

Various pharmacokinetic parameters--disposition half-life, t1/2,z, metabolic clearance CLm, volume of distribution V, intrinsic clearance of unbound drug CLuint, and unbound volume of distribution of tissues (distributive tissue volume/fraction of drug in tissue unbound, VT/fuT--are compared in rat and human for nine weakly acidic drugs, phenytoin, hexobarbital, pentobarbital, phenylbutazone, warfarin, tolbutamide, valproate, phenobarbital, and amobarbital, and six weakly basic drugs, quinidine, chlorpromazine, propranolol, pentazocin, antipyrine, and diazepam. With regard to all parameters, statistically significant correlations are obtained when parameters are plotted on a log-log plot. Correlation coefficients between the intrinsic parameters (CLuint or VT/fuT) were higher than those between the hybrid parameters (t1/2,z, CLm or V). In general, these drugs were metabolized ten times more rapidly in rat than in human. With regard to the tissue distribution of these drugs, there was little difference between rat and human. Predictions of CLm, V, and t1/2, in humans using rat data were successful for most drugs, with a few marked exceptions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3938813     DOI: 10.1007/bf01059331

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  62 in total

1.  Serum albumin and lipoproteins as the quinidine binding molecules in normal human sera.

Authors:  O G Nilsen
Journal:  Biochem Pharmacol       Date:  1976-05-01       Impact factor: 5.858

2.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

3.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

4.  Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.

Authors:  M Ehrnebo
Journal:  J Pharm Sci       Date:  1974-07       Impact factor: 3.534

5.  Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors:  I Odar-Cederlöf; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Effect of sulfaphenazole on tolbutamide distribution in rabbits: analysis of interspecies differences in tissue distribution of tolbutamide.

Authors:  O Sugita; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  J Pharm Sci       Date:  1984-05       Impact factor: 3.534

7.  Biliary excretion of diazepam in the rat.

Authors:  T Inaba; E Tsutsumi; W A Mahon; W Kalow
Journal:  Drug Metab Dispos       Date:  1974 Sep-Oct       Impact factor: 3.922

8.  Biliary excretion of diphenylhydantoin in the rat. Time-course studies.

Authors:  T Inaba; T Umeda
Journal:  Drug Metab Dispos       Date:  1975 Mar-Apr       Impact factor: 3.922

9.  Pharmocokinetics of hexobarbital in man after intravenous infusion.

Authors:  D D Breimer; C Honhoff; W Zilly; E Richter; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

10.  In vitro and in vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat.

Authors:  Y Igari; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

View more
  20 in total

Review 1.  Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors:  T Lavé; P Coassolo; B Reigner
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Prediction of hepatic clearance in human from in vitro data for successful drug development.

Authors:  Masato Chiba; Yasuyuki Ishii; Yuichi Sugiyama
Journal:  AAPS J       Date:  2009-04-30       Impact factor: 4.009

Review 3.  The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

Authors:  I Mahmood; J D Balian
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

4.  Reassessing models of hepatic extraction.

Authors:  D Ridgway; J A Tuszynski; Y K Tam
Journal:  J Biol Phys       Date:  2003-03       Impact factor: 1.365

5.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

6.  Relationships in the structure-tissue distribution of basic drugs in the rabbit.

Authors:  K Yokogawa; E Nakashima; J Ishizaki; H Maeda; T Nagano; F Ichimura
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

Authors:  Kyeong-Ryoon Lee; Yoon-Jee Chae; Han-Joo Maeng; Jeewoo Lee; Dae-Duk Kim; Saeho Chong; Chang-Koo Shim; Suk-Jae Chung
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-25       Impact factor: 2.745

8.  Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up.

Authors:  Y Mitsuhashi; Y Sugiyama; S Ozawa; T Nitanai; K Sasahara; K Nakamura; M Tanaka; T Nishimura; M Inaba; T Kobayashi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.

Authors:  Urban Fagerholm
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

10.  Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.

Authors:  W L Chiou; F H Hsu
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.